216 related articles for article (PubMed ID: 18580246)
21. F-18 FDG PET/CT can help differentiate SAPHO syndrome from suspected metastatic bone disease.
Patel CN; Smith JT; Rankine JJ; Scarsbrook AF
Clin Nucl Med; 2009 Apr; 34(4):254-7. PubMed ID: 19300064
[TBL] [Abstract][Full Text] [Related]
22. ¹⁸F-FDG-PET/CT in malignant mesothelioma.
Fuccio C; Spinapolice EG; Ferretti A; Castellucci P; Marzola MC; Trifirò G; Rubello D
Biomed Pharmacother; 2013 Jul; 67(6):539-42. PubMed ID: 23583476
[TBL] [Abstract][Full Text] [Related]
23. The Role of 18F-FDG PET/CT Integrated Imaging in Distinguishing Malignant from Benign Pleural Effusion.
Sun Y; Yu H; Ma J; Lu P
PLoS One; 2016; 11(8):e0161764. PubMed ID: 27560933
[TBL] [Abstract][Full Text] [Related]
24. Non-small cell lung cancer: evaluation of pleural abnormalities on CT scans with 18F FDG PET.
Schaffler GJ; Wolf G; Schoellnast H; Groell R; Maier A; Smolle-Jüttner FM; Woltsche M; Fasching G; Nicoletti R; Aigner RM
Radiology; 2004 Jun; 231(3):858-65. PubMed ID: 15105451
[TBL] [Abstract][Full Text] [Related]
25. Metastatic colon cancer to the lung with no detectable primary tumor, mimicking advanced primary lung cancer on F-18 FDG PET/CT imaging.
Kim HW; Won KS; Kwon KY; Choi BW; Zeon SK
Clin Nucl Med; 2010 Mar; 35(3):184-6. PubMed ID: 20173453
[TBL] [Abstract][Full Text] [Related]
26. [(18)F]-FDG PET and localized fibrous mesothelioma.
Cortes J; Rodriguez J; Garcia-Velloso MJ; Rodriguez-Espiteri N; Boan JF; Castellano JM; Torre W
Lung; 2003; 181(1):49-54. PubMed ID: 12879339
[TBL] [Abstract][Full Text] [Related]
27. Diagnosis of Paget's disease of the pelvis using F-18 FDG PET/CT.
Woo JH; Kim S; Choi SJ; Lee YH; Ji JD; Song GG
Int J Rheum Dis; 2010 Oct; 13(4):e51-4. PubMed ID: 21199453
[TBL] [Abstract][Full Text] [Related]
28. Fusion of metabolic function and morphology: sequential [18F]fluorodeoxyglucose positron-emission tomography/computed tomography studies yield new insights into the natural history of bone metastases in breast cancer.
Du Y; Cullum I; Illidge TM; Ell PJ
J Clin Oncol; 2007 Aug; 25(23):3440-7. PubMed ID: 17592153
[TBL] [Abstract][Full Text] [Related]
29. Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT.
Metser U; Even-Sapir E
Semin Nucl Med; 2007 May; 37(3):206-22. PubMed ID: 17418153
[TBL] [Abstract][Full Text] [Related]
30. 18 F-FDG avid lesion due to coexistent fibrous dysplasia in a child of embryonal rhabdomyosarcoma: source of false positive FDG-PET.
Basu S; Baghel NS; Puri A; Shet T; Merchant NH
J Cancer Res Ther; 2010; 6(1):92-4. PubMed ID: 20479556
[TBL] [Abstract][Full Text] [Related]
31. Malignant peritoneal mesothelioma with lower extremity metastasis: PET/CT imaging.
Le BB; Nguyen BD
Clin Nucl Med; 2015 Jan; 40(1):e68-70. PubMed ID: 24830875
[TBL] [Abstract][Full Text] [Related]
32. "One-stop-shop" staging: should we prefer FDG-PET/CT or MRI for the detection of bone metastases?
Heusner T; Gölitz P; Hamami M; Eberhardt W; Esser S; Forsting M; Bockisch A; Antoch G
Eur J Radiol; 2011 Jun; 78(3):430-5. PubMed ID: 19945240
[TBL] [Abstract][Full Text] [Related]
33. Improved detection of second primary cancer using integrated [18F] fluorodeoxyglucose positron emission tomography and computed tomography for initial tumor staging.
Choi JY; Lee KS; Kwon OJ; Shim YM; Baek CH; Park K; Lee KH; Kim BT
J Clin Oncol; 2005 Oct; 23(30):7654-9. PubMed ID: 16234527
[TBL] [Abstract][Full Text] [Related]
34. The appearance of osseous PEComa on F-18 FDG PET/CT.
Rakheja R; Abikhzer G; Alabed YZ; Nahal A; Lisbona R
Clin Nucl Med; 2012 Feb; 37(2):190-2. PubMed ID: 22228350
[TBL] [Abstract][Full Text] [Related]
35. The importance of 18F-FDG PET/CT, CT and X-rays in detecting primary stage III A lung cancer and the incidence of extra thoracic metastases.
Sharma R; Tripathi M; D'Souza M; Jaimini A; Saw SK; Singh D; Mishra A; Mondal A
Hell J Nucl Med; 2009; 12(1):22-5. PubMed ID: 19330177
[TBL] [Abstract][Full Text] [Related]
36. Detection of solitary humeral metastasis from pancreatic adenocarcinoma with F-18 FDG PET/CT.
Kim J; Quon A; Humke E; Ford JM; Koong AC
Clin Nucl Med; 2009 May; 34(5):312-3. PubMed ID: 19387214
[No Abstract] [Full Text] [Related]
37. Pleural tuberculosis mimicking malignant pleural mesothelioma by
Ai L; Wang W; Li Y
Med Clin (Barc); 2023 Nov; 161(9):415. PubMed ID: 37263842
[No Abstract] [Full Text] [Related]
38. Additional value of hybrid PET/CT fusion imaging vs. conventional CT scan alone in the staging and management of patients with malignant pleural mesothelioma.
Ambrosini V; Rubello D; Nanni C; Farsad M; Castellucci P; Franchi R; Fabbri M; Rampin L; Crepaldi G; Al-Nahhas A; Fanti S
Nucl Med Rev Cent East Eur; 2005; 8(2):111-5. PubMed ID: 16437396
[TBL] [Abstract][Full Text] [Related]
39. Serial 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) to monitor treatment of bone-dominant metastatic breast cancer predicts time to progression (TTP).
Specht JM; Tam SL; Kurland BF; Gralow JR; Livingston RB; Linden HM; Ellis GK; Schubert EK; Dunnwald LK; Mankoff DA
Breast Cancer Res Treat; 2007 Sep; 105(1):87-94. PubMed ID: 17268819
[TBL] [Abstract][Full Text] [Related]
40. Can calcified pulmonary metastases detected by (18)F-FDG PET/CT suggest the primary tumor?
Hong CM; Ahn BC
Hell J Nucl Med; 2016; 19(1):10-2. PubMed ID: 27035906
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
